Anti-CTLA4抗体[WKH203] (FITC) (ab33967)


  • 产品名称Anti-CTLA4抗体[WKH203] (FITC)
    参阅全部 CTLA4 一抗
  • 描述
    小鼠单克隆抗体[WKH203] to CTLA4 (FITC)
  • 偶联物FITC. Ex: 493nm, Em: 528nm
  • 特异性ab33967 also binds ligands CD80 and CD86.
  • 经测试应用适用于: Flow Cytmore details
  • 种属反应性
    与反应: Rat
  • 免疫原

    Fusion protein (Rat) purified rCTLA4hIg



Our Abpromise guarantee covers the use of ab33967 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
Flow Cyt
  • 应用说明Flow Cyt: Use neat. Use 10ul of the suggested working dilution to label 106 cells in 100ul.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • 靶标

    • 功能Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28.
    • 组织特异性Widely expressed with highest levels in lymphoid tissues. Detected in activated T-cells where expression levels are 30- to 50-fold less than CD28, the stimulatory coreceptor, on the cell surface following activation.
    • 疾病相关Genetic variation in CTLA4 influences susceptibility to systemic lupus erythematosus (SLE) [MIM:152700]. SLE is a chronic, inflammatory and often febrile multisystemic disorder of connective tissue. It affects principally the skin, joints, kidneys and serosal membranes. SLE is thought to represent a failure of the regulatory mechanisms of the autoimmune system.
      Note=Genetic variations in CTLA4 may influence susceptibility to Graves disease, an autoimmune disorder associated with overactivity of the thyroid gland and hyperthyroidism.
      Genetic variation in CTLA4 is the cause of susceptibility to diabetes mellitus insulin-dependent type 12 (IDDM12) [MIM:601388]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
      Genetic variation in CTLA4 is the cause of susceptibility to celiac disease type 3 (CELIAC3) [MIM:609755]. It is a multifactorial disorder of the small intestine that is influenced by both environmental and genetic factors. It is characterized by malabsorption resulting from inflammatory injury to the mucosa of the small intestine after the ingestion of wheat gluten or related rye and barley proteins. In its classic form, celiac disease is characterized in children by malabsorption and failure to thrive.
    • 序列相似性Contains 1 Ig-like V-type (immunoglobulin-like) domain.
    • 翻译后修饰N-glycosylation is important for dimerization.
      Phosphorylation at Tyr-201 prevents binding to the AP-2 adapter complex, blocks endocytosis, and leads to retention of CTLA4 on the cell surface.
    • 细胞定位Cell membrane. Exists primarily an intracellular antigen whose surface expression is tightly regulated by restricted trafficking to the cell surface and rapid internalisation and.
    • Information by UniProt
    • 数据库链接
    • 别名
      • ALPS5 antibody
      • CD 152 antibody
      • CD antibody
      • CD152 antibody
      • CD152 antigen antibody
      • CD152 isoform antibody
      • Celiac disease 3 antibody
      • CELIAC3 antibody
      • CTLA 4 antibody
      • CTLA-4 antibody
      • CTLA4 antibody
      • CTLA4_HUMAN antibody
      • Cytotoxic T cell associated 4 antibody
      • Cytotoxic T lymphocyte antigen 4 antibody
      • Cytotoxic T lymphocyte associated 4 antibody
      • Cytotoxic T lymphocyte associated 4, soluble isoform, included antibody
      • Cytotoxic T lymphocyte associated antigen 4 antibody
      • Cytotoxic T lymphocyte associated antigen 4 short spliced form antibody
      • Cytotoxic T lymphocyte associated protein 4 antibody
      • Cytotoxic T lymphocyte associated serine esterase 4 antibody
      • Cytotoxic T lymphocyte protein 4 antibody
      • Cytotoxic T-lymphocyte protein 4 antibody
      • Cytotoxic T-lymphocyte-associated antigen 4 antibody
      • GRD4 antibody
      • GSE antibody
      • ICOS antibody
      • IDDM12 antibody
      • insulin-dependent diabetes mellitus 12 antibody
      • Ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4 antibody
      • OTTHUMP00000216623 antibody
      see all

    Anti-CTLA4 antibody [WKH203] (FITC) (ab33967)参考文献

    ab33967 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab33967.
    Please use the links above to contact us or submit feedback about this product.